Nursing units at Fox Chase Cancer Center were recently rewarded with a sweet treat after their work led to a significant decrease in catheter-associated urinary tract infections in patients.Over the last year, nursing units at Fox Chase have been working ha...

The Office of Clinical Research at Fox Chase Cancer Center is kicking one out of the park in support of the AstraZeneca Hope Lodge of the American Cancer Society. Sixteen members of the department – including some of their significant others – came toget...

Fox Chase Cancer Center encourages all individuals to start taking steps to reduce their risk for cancer. According to the American Cancer Society (ACS), more than one million Americans are diagnosed with cancer every year. Fortunately, people can help prev...

As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, Fox Chase Cancer Center offers our patients the most advanced treatment options through clinical trials, many of which are not readily available elsewhere. Our nationally ranked do...

 Fox Chase Cancer Center researchers have identified a way forward for personalized cancer treatments for a wide range of cancers. Their findings can provide new insight into the mechanisms of a small molecule and investigational new drug for cancer ca...

From Prevention Matters Newsletter, Spring 2016 [PDF] By Elias Obeid, MD, MPH Metastatic castration-resistant prostate cancer (mCRPC) is when the cancer has spread to parts of the body other than the prostate, and is able to grow and spread despite tre...